{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:13:14Z","timestamp":1794949994721,"version":"4.9.1"},"reference-count":51,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>First description of the relevance of the CAR engineering approach to develop CAR-CD8+ Tregs for clinical trials in transplantation. A2-CAR CD8+ Treg interactions with HLA-A*02+ ECs induce a noncytotoxic fine-tuned and protolerogenic activation of ECs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000411","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T15:38:56Z","timestamp":1573832336000},"page":"3522-3538","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":82,"title":["Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice"],"prefix":"10.1182","volume":"3","author":[{"given":"S\u00e9verine","family":"B\u00e9zie","sequence":"first","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5870-4615","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Charreau","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Vimond","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Lasselin","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"G\u00e9rard","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Nerri\u00e8re-Daguin","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3500-2172","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9rique","family":"Bellier-Waast","sequence":"additional","affiliation":[{"name":"Chirurgie Plastique Reconstructrice et Esth\u00e9tique, CHU de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Duteille","sequence":"additional","affiliation":[{"name":"Chirurgie Plastique Reconstructrice et Esth\u00e9tique, CHU de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-0631","authenticated-orcid":false,"given":"Carole","family":"Guillonneau","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie, Unit\u00e9 Mixte de Recherche 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France;"},{"name":"Institut de Transplantation Urologie-N\u00e9phrologie, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France;"},{"name":"LabEx \u201cImmunotherapy, Graft, Oncology,\u201d Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"24","key":"2019111515385391600_B1","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111515385391600_B2","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111515385391600_B3","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111515385391600_B4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/TP.0000000000002242","article-title":"Contemporary strategies and barriers to transplantation tolerance","volume":"102","author":"Ezekian","year":"2018","journal-title":"Transplantation"},{"issue":"1","key":"2019111515385391600_B5","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex vivo expanded recipient regulatory t cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"2019111515385391600_B6","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"2019111515385391600_B7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"2019111515385391600_B8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/intimm\/dxh122","article-title":"Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells","volume":"16","author":"Nishimura","year":"2004","journal-title":"Int Immunol"},{"issue":"1","key":"2019111515385391600_B9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"issue":"2","key":"2019111515385391600_B10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","article-title":"In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance","volume":"109","author":"Golshayan","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2019111515385391600_B11","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1172\/JCI33185","article-title":"Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice","volume":"118","author":"Tsang","year":"2008","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111515385391600_B12","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"2019111515385391600_B13","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI71533","article-title":"MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection","volume":"124","author":"Picarda","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111515385391600_B14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111515385391600_B15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111515385391600_B16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"2019111515385391600_B17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111515385391600_B18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am J Transplant"},{"key":"2019111515385391600_B19","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2017.02014","article-title":"Ex vivo expanded human non-cytotoxic CD8+CD45RClow\/- Tregs efficiently delay skin graft rejection and GVHD in humanized mice","volume":"8","author":"B\u00e9zie","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"2019111515385391600_B20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/TP.0000000000002258","article-title":"Advances on CD8+ Treg cells and their potential in transplantation","volume":"102","author":"B\u00e9zie","year":"2018","journal-title":"Transplantation"},{"issue":"4","key":"2019111515385391600_B21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI28801","article-title":"CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase","volume":"117","author":"Guillonneau","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111515385391600_B22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4049\/jimmunol.1000120","article-title":"Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"issue":"10","key":"2019111515385391600_B23","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"Xystrakis","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111515385391600_B24","doi-asserted-by":"crossref","first-page":"e90088","DOI":"10.1172\/jci.insight.90088","article-title":"Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells","volume":"2","author":"Picarda","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"2019111515385391600_B25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/ajt.12515","article-title":"Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells","volume":"14","author":"Dai","year":"2014","journal-title":"Am J Transplant"},{"issue":"10","key":"2019111515385391600_B26","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1172\/JCI81227","article-title":"IL-34 is a Treg-specific cytokine and mediates transplant tolerance","volume":"125","author":"B\u00e9zie","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111515385391600_B27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.1200886","article-title":"CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity","volume":"189","author":"Beres","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"2019111515385391600_B28","doi-asserted-by":"crossref","first-page":"e1146842","DOI":"10.1080\/2162402X.2016.1146842","article-title":"CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in mice","volume":"5","author":"Heinrichs","year":"2016","journal-title":"OncoImmunology"},{"issue":"9","key":"2019111515385391600_B29","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1600-6143.2012.04120.x","article-title":"Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells","volume":"12","author":"Lerret","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"2019111515385391600_B30","doi-asserted-by":"crossref","first-page":"e0119686","DOI":"10.1371\/journal.pone.0119686","article-title":"Fibrinogen-like protein 2\/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells","volume":"10","author":"B\u00e9zie","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"2019111515385391600_B31","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1681\/ASN.2012080814","article-title":"MICA variant promotes allosensitization after kidney transplantation","volume":"24","author":"Tonnerre","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"2019111515385391600_B32","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","article-title":"Immune regulatory cell infusion for graft-versus-host disease prevention and therapy","volume":"131","author":"Blazar","year":"2018","journal-title":"Blood"},{"issue":"4 Suppl","key":"2019111515385391600_B33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/imt.11.37","article-title":"T-cell receptor specificity of CD8(+) Tregs in allotransplantation","volume":"3","author":"Picarda","year":"2011","journal-title":"Immunotherapy"},{"issue":"24","key":"2019111515385391600_B34","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7655","key":"2019111515385391600_B35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"issue":"7","key":"2019111515385391600_B36","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1053\/j.gastro.2008.02.060","article-title":"Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice","volume":"134","author":"Elinav","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"2019111515385391600_B37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/tan.12356","article-title":"The HLA-net GENE[RATE] pipeline for effective HLA data analysis and its application to 145 population samples from Europe and neighbouring areas","volume":"83","author":"Nunes","year":"2014","journal-title":"Tissue Antigens"},{"issue":"3","key":"2019111515385391600_B38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/iji.12000","article-title":"HLA-A, -B, -DR allele group frequencies in 7007 kidney transplant list patients in 27 UK centres","volume":"40","author":"Burt","year":"2013","journal-title":"Int J Immunogenet"},{"issue":"8","key":"2019111515385391600_B39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/TP.0000000000002251","article-title":"Generation of immunodeficient rats with Rag1 and Il2rg gene deletions and human tissue grafting models","volume":"102","author":"M\u00e9noret","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"2019111515385391600_B40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"issue":"5","key":"2019111515385391600_B41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.coi.2004.07.011","article-title":"New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance","volume":"16","author":"Jiang","year":"2004","journal-title":"Curr Opin Immunol"},{"issue":"83","key":"2019111515385391600_B42","doi-asserted-by":"crossref","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci Transl Med"},{"issue":"1","key":"2019111515385391600_B43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ajt.12509","article-title":"Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy","volume":"14","author":"Lee","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"2019111515385391600_B44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ajt.12629","article-title":"Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells","volume":"14","author":"Landwehr-Kenzel","year":"2014","journal-title":"Am J Transplant"},{"issue":"12","key":"2019111515385391600_B45","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.4049\/jimmunol.173.12.7647","article-title":"T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity","volume":"173","author":"Chmielewski","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"2019111515385391600_B46","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm.1779","article-title":"Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor","volume":"14","author":"Varela-Rohena","year":"2008","journal-title":"Nat Med"},{"issue":"15","key":"2019111515385391600_B47","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2011-09-377051","article-title":"TCR affinity and specificity requirements for human regulatory T-cell function","volume":"119","author":"Plesa","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111515385391600_B48","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1600-6143.2011.03650.x","article-title":"The potency of allospecific Tregs cells appears to correlate with T cell receptor functional avidity","volume":"11","author":"Tsang","year":"2011","journal-title":"Am J Transplant"},{"issue":"10","key":"2019111515385391600_B49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/leu.2017.57","article-title":"Fully human CD19-specific chimeric antigen receptors for T-cell therapy","volume":"31","author":"Sommermeyer","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2019111515385391600_B50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12896-016-0322-5","article-title":"Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies","volume":"17","author":"Ouisse","year":"2017","journal-title":"BMC Biotechnol"},{"issue":"6","key":"2019111515385391600_B51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3522\/1539603\/advancesadv2019000411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/22\/3522\/1539603\/advancesadv2019000411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T15:39:23Z","timestamp":1573832363000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/22\/3522\/428751\/Human-CD8-Tregs-expressing-a-MHCspecific-CAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":51,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,11,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000411","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}